FDA Drug Recalls

Recalls / Class II

Class IID-1387-2020

Product

Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.

Affected lot / code info
Lot #: B0796217-020920, Exp. Date: 02/28/2021

Why it was recalled

FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.

Recalling firm

Firm
RemedyRepack Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
625 Kolter Dr Ste 4, N/A, Indiana, Pennsylvania 15701-3571

Distribution

Quantity
498 tablets
Distribution pattern
Product was distributed to MN.

Timeline

Recall initiated
2020-06-29
FDA classified
2020-07-14
Posted by FDA
2020-07-22
Terminated
2020-09-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1387-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.